As stated in our extensive report, the Global Breast Reconstruction Market accounted for USD 562.9 Million in the year 2021.Breast Reconstruction is a surgical procedure that uses surgery to create a new breast shape or mound. Breast Reconstruction may be done after a mastectomy (if the entire breast is removed, it may include related lymph nodes or muscles) or after breast-conserving surgery (if only part of the breast is removed). Breast Reconstruction is often done to restore breast symmetry, and the process can begin immediately after mastectomy (immediate reconstruction) or shortly after mastectomy (delayed reconstruction). Breast Reconstruction decisions are based on various factors, including general health, cancer treatment status, body shape, strengths and weaknesses of each option, and personal lifestyle. Breast Reconstruction is associated with many possible complications, including pain, poor incision healing, anesthesia problems, and scar tissue formation.
Increasing emphasis on aesthetic appearance will drive the Global Breast Reconstruction Market demand over the forecast period. By 2028, the market is expected to be caused by rising breast cancer prevalence, rising obesity rates, and rising awareness of Breast Reconstruction surgery. In addition, according to research published by The American Cancer Society, individuals who have breast-conserving reconstruction surgery followed by radiation therapy had a lower risk of cancer recurrence and significantly improved survival rates.
Breast cancer is the fifth leading cause of cancer-related death in women. At least one in four women diagnosed with cancer has breast cancer, and such an astonishing increase drives the need for effective treatment. The steadily increasing prevalence of breast cancer worldwide has significantly increased the demand for Breast Reconstruction surgery. The increasing prevalence of genetic diseases in women, accompanied by increased health care costs and government support, is driving the growth of the Breast Reconstruction Market. According to the American Cancer Society, about 1.7 million new cancer cases are expected to be diagnosed by 2018, and more than 600 thousand Americans are expected to die of cancer in 2018. Increased spending on Research and Development (R&D) activities has boosted the growth of the Breast Reconstruction Market. Cancer Research UK has spent $ 518 million nationwide on cancer research to accelerate cancer survival by 75% by 2034. The organization aims to increase cancer research funding to 2.6% of GDP by 2023. Increasing awareness of people, favorable reimbursement policies, and the availability of treatment are driving the growth of the Breast Reconstruction Market.
North Americais likely to hold a significant proportion of the Global Breast Reconstruction Market in 2021, owing to the increased number of Breast Reconstruction procedures and a growing emphasis on aesthetic appearance. Furthermore, during the projection period, the rising prevalence of cancer and obesity is expected to drive the use of Breast Reconstruction surgeries in this region.
Some of the key players in the Global Breast Reconstruction Market include- Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics Inc. (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), Silimed (Brazil) and others.